These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma. Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395 [TBL] [Abstract][Full Text] [Related]
46. Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas. Kim JC; Roh SA; Cho DH; Kim TW; Yoon SN; Kim CW; Yu CS; Kim SY; Kim YS Anticancer Res; 2009 Aug; 29(8):3115-23. PubMed ID: 19661324 [TBL] [Abstract][Full Text] [Related]
47. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer]. Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579 [TBL] [Abstract][Full Text] [Related]
48. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
49. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics. Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947 [TBL] [Abstract][Full Text] [Related]
51. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802 [TBL] [Abstract][Full Text] [Related]
52. A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancer. Morris M; Platell C; Iacopetta B Anticancer Res; 2007; 27(4C):2833-8. PubMed ID: 17695456 [TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Shia J; Klimstra DS; Nitzkorski JR; Low PS; Gonen M; Landmann R; Weiser MR; Franklin WA; Prendergast FG; Murphy L; Tang LH; Temple L; Guillem JG; Wong WD; Paty PB Hum Pathol; 2008 Apr; 39(4):498-505. PubMed ID: 18342661 [TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477 [TBL] [Abstract][Full Text] [Related]
55. p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. Wassermann S; Scheel SK; Hiendlmeyer E; Palmqvist R; Horst D; Hlubek F; Haynl A; Kriegl L; Reu S; Merkel S; Brabletz T; Kirchner T; Jung A Gastroenterology; 2009 Jan; 136(1):196-205.e2. PubMed ID: 18951899 [TBL] [Abstract][Full Text] [Related]
56. Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. Yamaguchi T; Iijima T; Mori T; Takahashi K; Matsumoto H; Miyamoto H; Hishima T; Miyaki M Dis Colon Rectum; 2006 Mar; 49(3):399-406. PubMed ID: 16421660 [TBL] [Abstract][Full Text] [Related]
57. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152 [TBL] [Abstract][Full Text] [Related]
58. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma. Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138 [TBL] [Abstract][Full Text] [Related]
59. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744 [TBL] [Abstract][Full Text] [Related]
60. [Relationship between expression of p27 and DNA ploidy in colorectal carcinoma]. Fan JW; Fan PX; Wang Y; Zhang XQ Ai Zheng; 2002 Jan; 21(1):54-7. PubMed ID: 12500398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]